Join Our Mailing List:
 
Follow Us:
Shop Contact Us
You have 0  Item in Cart | View Cart
310-841-2600
Featured Events
Sunday, October 15
8th Annual STOP CANCER 5|10K Run|Walk
On your mark, get set, go! Be part of the 8th Annual 5|10K Run|Walk ... More
View All Events
Ling Li, Ph.D.
Research performed at: City of Hope Comprehensive Cancer Center
Specialty/Research Area: Acute Myeloid Leukemia, Leukemia Stem Cells
Award Year: 2017
Career Summary:  Dr. Li is an Assistant Professor of Division of hematopoietic stem cell and leukemia Research within the hematologic Malignancies and stem cell Transplantation Institute at City of Hope (Duarte, CA). He received his Ph.D. from the Cancer Institute of Zhejiang University School of Medicine, China. He did his postdoctoral fellowship at City of Hope from 2008–2012. In 2013, he was promoted to the position of Research Scientist. He joined COH as an Assistant Professor in 2015. In addition to his STOP CANCER Award, Dr. Li is the recipient of an NIH K99/R00 Pathway to Independence Award (2014). This year, Dr. Li was also awarded a grant from The Margaret E. Early Medical Research Trust.
 
Year STOP CANCER Award was received:  2017 Research Career Development Award 
 
Description of research performed:  Dr. Li is very active in the area of leukemia research. His research focuses on studying the molecular mechanisms that initiate or maintain the leukemia, specifically acute myeloid leukemia (AML).
 
Results of research:  Dr. Li has made great contributions to the field of leukemia stem cell (LSC) research by bringing a greater understanding of the mechanisms of resistance of these cells to the current therapies. Dr. Li’s laboratory is currently studying epigenetic-related resistance mechanisms of LSC to tyrosine kinase inhibitors (TKI) treatment. The primary goal of this effort is to develop novel therapeutics to specifically target LSC and advance these strategies to clinical trials in AML.

STOP CANCER is committed to funding the most promising and innovative scientists in their early research of all forms of cancer prevention, treatment, cures and subsequent clinical applications. STOP CANCER works primarily with local National Cancer Institute-designated Comprehensive Cancer Centers and other qualified institutions in the United States to carry out its mission.

Copyright © 2017 STOP CANCER. All Rights Reserved. | Privacy Policy